Issue navigation
Volume 79, Issue 4, April 2024
Review
Why do we use 100 mg of clofazimine in TB and NTM treatment?
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 697–702, https://doi.org/10.1093/jac/dkae041
Systematic Reviews
Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 703–711, https://doi.org/10.1093/jac/dkae003
Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 712–721, https://doi.org/10.1093/jac/dkae026
Do dietary interventions exert clinically important effects on the bioavailability of β-lactam antibiotics? A systematic review with meta-analyses
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 722–757, https://doi.org/10.1093/jac/dkae028
Original Research
Differences in antibiotic use between COPD and non-COPD residents based on the health information system
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 758–766, https://doi.org/10.1093/jac/dkae016
Diagnosis-linked antibiotic prescribing quality indicators: demonstrating feasibility using practice-based routine primary care data, reliability, validity and their potential in antimicrobial stewardship
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 767–773, https://doi.org/10.1093/jac/dkae017
Effect of different strategies for excluding duplicate cultures on the correlation between hospital resistance rates and antibiotic consumption
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 774–778, https://doi.org/10.1093/jac/dkae019
Novel sequence type of carbapenem-resistant Acinetobacter pittii ST1451 with enhanced virulence isolated from septicaemic neonates in India
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 779–783, https://doi.org/10.1093/jac/dkae024
Evaluation of temocillin efficacy against KPC-2-producing Klebsiella pneumoniae isolates in a hollow-fibre infection model
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 784–789, https://doi.org/10.1093/jac/dkae027
Phenotypic and genetic characterization of antimicrobial resistance in Salmonella enterica serovar Choleraesuis isolates from humans and animals in Spain from 2006 to 2021
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 790–800, https://doi.org/10.1093/jac/dkae029
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 801–809, https://doi.org/10.1093/jac/dkae032
Identification of a CTX-M-255 β-lactamase containing a G239S substitution selectively conferring resistance to penicillin/β-lactamase inhibitor combinations
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 810–814, https://doi.org/10.1093/jac/dkae033
Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry—proof of concept for seven clinically relevant antimicrobials
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 815–819, https://doi.org/10.1093/jac/dkae034
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 820–825, https://doi.org/10.1093/jac/dkae035
Carriage of methicillin-resistant Staphylococcus aureus in children <6 years old: a retrospective follow-up study of the natural course and effectiveness of decolonization treatment
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 826–834, https://doi.org/10.1093/jac/dkae036
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 835–845, https://doi.org/10.1093/jac/dkae037
Global spread of the linezolid-resistant Enterococcus faecalis ST476 clonal lineage carrying optrA
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 846–850, https://doi.org/10.1093/jac/dkae039
Identification and evolution of ICE-PmuST394: a novel integrative conjugative element in Pasteurella multocida ST394
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 851–858, https://doi.org/10.1093/jac/dkae040
COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 859–867, https://doi.org/10.1093/jac/dkae042
Antimicrobial susceptibility profile of clinically relevant Bacteroides, Phocaeicola, Parabacteroides and Prevotella species, isolated by eight laboratories in the Netherlands
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 868–874, https://doi.org/10.1093/jac/dkae043
Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 875–882, https://doi.org/10.1093/jac/dkae046
Development and validation of an UPLC–MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 883–890, https://doi.org/10.1093/jac/dkae047
Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 891–896, https://doi.org/10.1093/jac/dkae048
Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 897–902, https://doi.org/10.1093/jac/dkae049
Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 903–917, https://doi.org/10.1093/jac/dkae051
Temocillin for febrile urinary tract infections caused by ESBL-producing Enterobacteriaceae in children: a monocentric exposed/non-exposed study
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 918–922, https://doi.org/10.1093/jac/dkae053
Research Letters
Emergence of NDM-1, VIM-4 and CTX-M-15-co-harbouring Enterobacter xiangfangensis in a bloodstream infection
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 923–925, https://doi.org/10.1093/jac/dkae008
Healthcare-associated vanA-positive Enterococcus faecium clone ST612 emerging as pathogen of companion animals in Brazil
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 926–928, https://doi.org/10.1093/jac/dkae010
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 928–930, https://doi.org/10.1093/jac/dkae018
Modification of the penicillin-binding-protein 3 as a source of resistance to broad-spectrum cephalosporins in Escherichia coli
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 4, April 2024, Pages 930–932, https://doi.org/10.1093/jac/dkae020
